Breaking News

8 key players inside RFK Jr.’s HHS

March 18, 2025
Clockwise, from top: Stefanie Spear, Matthew Memoli, Heather Flick, and Drew Snyder of HHS.
Photo illustration: STAT; Photos: HHS, AP

STAT+ | 8 key players inside RFK Jr.'s HHS

Conservative stalwarts, Trump loyalists, friends of Kennedy — a look at eight key players at HHS as RFK Jr. and MAHA take charge.

By Isabella Cueto


STAT+ | Congress created a unique plan to save rural hospitals — but few are using it

'A stopgap to the hospital closure crisis,' known as the Rural Emergency Hospital designation, is used by only 38 facilities because of strings attached.

By Tara Bannow


STAT+ | Eric Green is out as head of National Human Genome Research Institute

Eric Green, National Human Genome Research Institute director, steps aside as Trump Administration shakes up the National Institutes of Health.

By Megan Molteni, Anil Oza, Jason Mast, Matthew Herper, and Lizzy Lawrence



Kristoffer Tripplaar/Sipa via AP

STAT+ | Teenager who received Elevidys, Sarepta's Duchenne gene therapy, dies 

The patient suffered from liver failure, a side effect that has been seen with other gene therapy treatments over the last two decades. 

By Jason Mast


Private equity 'gobbling' up care facilities for people with disabilities

Private equity firms are acquiring facilities that care for people with intellectual or developmental disabilities at an alarming rate.

By O. Rose Broderick


Q&A: How one advocacy group is stepping in to bolster transgender data

The CDC is no longer processing transgender identity data, so researchers will have to turn to other data-gathering sources.

By Theresa Gaffney


John-Arne Røttingen is the CEO of the Wellcome Trust.
Wellcome

'No one can fill that gap': Why a global health leader sees U.S. funding as irreplaceable

CEO of Wellcome Trust says global health organizations must learn to live with less, that philanthropy can't replace cuts to USAID and other expenditures.

By Helen Branswell


Opinion: Banning direct-to-consumer drug ads won't work

Instead of an all-out ban, regulators need to install stricter regulations on transparency and accuracy in pharma ad design and creative.

By Hal Rosenbluth


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.

No comments